Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes

Greg H. Tesch(Monash University), Josephine M. Forbes(Translational Research Institute), Allison R. Pettit(Translational Research Institute), A. Richard Kitching(Monash Medical Centre), Danielle J. Borg(Translational Research Institute), Domenica A. McCarthy(Translational Research Institute), David J. Nikolic‐Paterson(Monash University), Felicia Y. T. Yap(Baker Heart and Diabetes Institute), Adeline Tan(Albert Einstein College of Medicine), Joshua Kausman(Monash Medical Centre), Micheal Ward(Translational Research Institute), Amelia K. Fotheringham(Translational Research Institute), Brooke E. Harcourt(Albert Einstein College of Medicine), Linda A. Gallo(Translational Research Institute), Karly C. Sourris(Baker Heart and Diabetes Institute), Shaun A. Summers(Pediatric Nephrology of Alabama)
Diabetologia
June 23, 2014
10.1007/s00125-014-3291-z
Cited by 29

Related Papers

An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation
|Blood|2010|517
RAGE-Induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes
|Journal of the American Society of Nephrology|2009|461
Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product–Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-α–Dependent Pathway
|Diabetes|2007|346
Resveratrol Inhibits Renal Fibrosis in the Obstructed Kidney
|American Journal Of Pathology|2010|195
Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes
|Clinical Science|2016|167